TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% OMNI BY OSRX

REGISTERED

Combined Mark

TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% OMNI BY OSRX

Key Information

Serial Number

88423694

Registration Number

6342255

Status

Registered

Ownership

Owner Name

OSRX, Inc.

Type: Organization / Corporation

Address

1120 Kensington Ave., Suite E

Missoula, MT 59801

Critical Dates

First Use Date

May 1, 2019

Filing Date

May 9, 2019

Registration Date

May 4, 2021

Mark Descriptions

Goods

Class 5

Ophthalmic preparations containing timolol, brimonidine tartrate, and dorzolamide; "TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE OPHTHALMIC SOLUTION 0.5% / 0.2% / 2%"

Mark Elements

Text Mark

TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% OMNI BY OSRX

Trademark Timeline

First Use

May 1, 2019

Filing Date

May 9, 2019

Publication Date

Mar 3, 2020

Registration Date

May 4, 2021

USPTO Records

No documents found for this trademark.

Never miss important updates for TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% OMNI BY OSRX

Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach